PAR 4.76% 22.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-4075

  1. 113 Posts.
    lightbulb Created with Sketch. 54
    Totally agree. Just saying there must have been much hand-wringing coming up with a target well below the options strike price they advised just over 6 months ago.

    How gutting is it that we may well be back with hands out asking them to organise another raise within the year. Probably over a weekend!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.